Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.3, 2011-03, pp. : 325-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Placental Drug Transporters

Current Drug Metabolism, Vol. 5, Iss. 1, 2004-02 ,pp. : 125-131

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphisms of Drug-Metabolising Enzymes and Drug Transporters in the Chemotherapeutic Treatment of Cancer

By Bosch Tessa M.

Clinical Pharmacokinetics, Vol. 45, Iss. 3, 2006-01 ,pp. : 253-285

Adis International

Access to resources Recommend Favorite

Interindividual variability in oral antidiabetic drug disposition and response: the role of drug transporter polymorphisms

By Pacanowski Michael A Hopley Charles W Aquilante Christina L

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 529-544

Informa Healthcare

Access to resources Recommend Favorite

Oral Antidiabetic Agents: A Guide to Selection

By Scheen J. Lefèbvre P.J.

Drugs, Vol. 55, Iss. 2, 1998-02 ,pp. : 225-236

Adis International

Access to resources Recommend Favorite

Genetic Polymorphisms of Human Sulfate Transporters

Current Pharmacogenomics, Vol. 5, Iss. 4, 2007-12 ,pp. : 262-274

Bentham Science Publishers

Access to resources Recommend Favorite